Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
Keywords:
Bone Neoplasms/genetics/mortality/pathology
Cortactin/genetics/metabolism
Osteosarcoma/genetics/mortality/pathology
Citation:
Folio C, Zalacain M, Zandueta C, Ormazabal C, Sierrasesumaga L, San Julian M, et al. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomark 2011 -2012;10(1):35-41.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.